Regenxbio Issuance Of Capital Stock from 2010 to 2024

RGNX Stock  USD 10.01  0.46  4.82%   
Regenxbio Issuance Of Capital Stock yearly trend continues to be fairly stable with very little volatility. Issuance Of Capital Stock will likely drop to about 6.4 M in 2024. During the period from 2010 to 2024, Regenxbio Issuance Of Capital Stock regression line of annual values had r-squared of  0.52 and arithmetic mean of  129,469,600. View All Fundamentals
 
Issuance Of Capital Stock  
First Reported
2010-12-31
Previous Quarter
6.7 M
Current Value
6.4 M
Quarterly Volatility
92.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Issuance Of Capital Stock Growth Pattern

Below is the plot of the Issuance Of Capital Stock of Regenxbio over the last few years. It is Regenxbio's Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Issuance Of Capital Stock10 Years Trend
Slightly volatile
   Issuance Of Capital Stock   
       Timeline  

Regenxbio Issuance Of Capital Stock Regression Statistics

Arithmetic Mean129,469,600
Geometric Mean47,542,508
Coefficient Of Variation71.34
Mean Deviation83,891,467
Median189,716,000
Standard Deviation92,363,138
Sample Variance8530.9T
Range214.9M
R-Value(0.72)
Mean Square Error4445.2T
R-Squared0.52
Significance0
Slope(14,837,879)
Total Sum of Squares119433.3T

Regenxbio Issuance Of Capital Stock History

20246.4 M
20236.7 M
20221.7 M
2021216.4 M
20201.8 M
20191.6 M

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Issuance Of Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Issuance Of Capital Stock6.7 M6.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.